Trial Profile
Randomised controlled single and chronic dosing crossover comparison of extra fine particle formoterol and coarse particle salmeterol in asthmatic patients with persistent small airways dysfunction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Formoterol (Primary) ; Salmeterol
- Indications Allergic asthma
- Focus Pharmacodynamics
- 04 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Aug 2014 Planned End Date changed from 1 Jul 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 11 Aug 2014 Planned primary completion date changed from 1 Jul 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.